mGC Offers a Digital Solution to the Genetic Counseling Gap A recent article published in JAMA Oncology found that the majority (63%) of women who pursued genetic testing for BRCA testing never received genetic counseling. Researchers surveyed women whose clinicians ordered BRCA testing and a total of 3,874 patients completed the questionnaire assessing BRCA knowledge,…

Read More

It is well-known that women who carry a mutation in BRCA1 or BRCA2 are at high risk to develop both breast (50-85% lifetime risk) and ovarian (15-60% lifetime risk) cancer. Because the screening options for ovarian cancer (transvaginal ultrasound, the blood test CA-125 and physical exam), are not effective at finding ovarian cancers at earlier,…

Read More